Fiji vs Malaysia: Cause of death, by non-communicable diseases, ages 5-14, male
Fiji
36.6%
in 2021
Malaysia
37.2%
in 2021
Fiji rank
85th
Malaysia rank
84th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Fiji
- Malaysia
How they compare
Malaysia currently reports 37.2% against 36.6% in Fiji, a difference of 0.6%.
Across all 6 years both countries report, Malaysia has been ahead every year.
Fiji ranks 85th and Malaysia ranks 84th of 185 countries.
Malaysia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Fiji | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.3% | 36.5% | 0.2% | Malaysia |
| 2010s | 39.1% | 40.8% | 1.6% | Malaysia |
| 2020s | 39.1% | 41.0% | 1.9% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Fiji or Malaysia?
- Malaysia, at 37.2% against 36.6% in Fiji as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Fiji and Malaysia?
- 0.6%, with Malaysia ahead.
- How many years of comparable data are there for Fiji and Malaysia?
- 6 years are reported by both, from 2000 to 2021.
- How do Fiji and Malaysia rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Fiji ranks 85th and Malaysia ranks 84th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.